甘氨唑仑与苯巴比妥在新生儿惊厥管理中的比较
研究在围产期窒息的新生羔羊模型中比较甘氨唑仑与苯巴比妥对惊厥活动和神经病理的作用。甘氨唑仑使惊厥次数较窒息组减少86.4%,并减轻海马CA1、CA3区及皮层神经元变性和丘脑神经炎症,而苯巴比妥未见此效应。作者认为甘氨唑仑在该模型中惊厥控制优于苯巴比妥且具神经保护作用。
要点
- 围产期窒息羔羊中,甘氨唑仑使惊厥次数较窒息组减少86.4%。
- 甘氨唑仑组总惊厥持续时间短于未治疗窒息组。
- 苯巴比妥未减少SE惊厥次数或持续时间,也未减轻神经元变性。
核心结论
- 在围产期窒息模型中,甘氨唑仑的惊厥控制优于苯巴比妥,并对新生脑有神经保护作用,为新生儿惊厥治疗提供了新机会。
研究设计与样本
- 足月羔羊出生时通过脐带闭塞诱导窒息,6小时时分别给予甘氨唑仑(5mg/kg推注后5mg/kg/天用2天)或苯巴比妥(20mg/kg推注后5mg/kg/天用2天)。
- 用连续振幅整合脑电图记录分类异常脑活动为刻板演变(SE)惊厥、癫痫样放电(EDs)和癫痫样瞬变(ETs),48小时处死行脑病理检查。
主要发现
- 窒息引起异常脑活动,包括SE惊厥在18至20小时达峰,以及EDs、ETs,并诱导神经元变性和神经炎症。
- 甘氨唑仑治疗使惊厥次数较窒息组减少86.4%。
- 窒息+甘氨唑仑组总惊厥持续时间短于未治疗窒息组。
- 窒息组与窒息+苯巴比妥组之间SE惊厥次数或SE惊厥持续时间无差异。
- 甘氨唑仑治疗(而非苯巴比妥)减轻海马CA1和CA3区及皮层神经元变性,甘氨唑仑还减轻丘脑神经炎症。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Seizures are more common in the neonatal period than at any other stage of life. Phenobarbital is the first-line treatment for neonatal seizures and is at best effective in approximately 50% of babies, but may contribute to neuronal injury. Here, we assessed the efficacy of phenobarbital versus the synthetic neurosteroid, ganaxolone, to moderate seizure activity and neuropathology in neonatal lambs exposed to perinatal asphyxia. METHODS: Asphyxia was induced via umbilical cord occlusion in term lambs at birth. Lambs were treated with ganaxolone (5mg/kg/bolus then 5mg/kg/day for 2 days) or phenobarbital (20mg/kg/bolus then 5mg/kg/day for 2 days) at 6 hours. Abnormal brain activity was classified as stereotypic evolving (SE) seizures, epileptiform discharges (EDs), and epileptiform transients (ETs) using continuous amplitude-integrated electroencephalographic recordings. At 48 hours, lambs were euthanized for brain pathology. RESULTS: Asphyxia caused abnormal brain activity, including SE seizures that peaked at 18 to 20 hours, EDs, and ETs, and induced neuronal degeneration and neuroinflammation. Ganaxolone treatment was associated with an 86.4% reduction in the number of seizures compared to the asphyxia group. The total seizure duration in the asphyxia+ganaxolone group was less than the untreated asphyxia group. There was no difference in the number of SE seizures between the asphyxia and asphyxia+phenobarbital groups or duration of SE seizures. Ganaxolone treatment, but not phenobarbital, reduced neuronal degeneration within hippocampal CA1 and CA3 regions, and cortical neurons, and ganaxolone reduced neuroinflammation within the thalamus. INTERPRETATION: Ganaxolone provided better seizure control than phenobarbital in this perinatal asphyxia model and was neuroprotective for the newborn brain, affording a new therapeutic opportunity for treatment of neonatal seizures. ANN NEUROL 2022;92:1066-1079.
引用
- Miller SL, Bennet L, Sutherland AE, et al. Ganaxolone versus Phenobarbital for Neonatal Seizure Management. Ann Neurol. 2022. PMID: 36054160. doi:10.1002/ana.26493
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。